HKU Scholars Hub: Browsing DSpace

Browsing by Author Yoon, JH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 9 of 9

	Title	Author(s)	Issue Date	Views
	A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma Journal:Clinical Cancer Research	Lim, HY Heo, J Choi, HJ Lin, CY Yoon, JH Hsu, C Rau, KM Poon, RTP Yeo, W	2014	70
	An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma Journal:The Oncologist	El Dika, I Lim, HY Yong, WP Lin, CC Yoon, JH Modiano, M Freilich, B Choi, HJ Chao, TY Kelley, RK Brown, J Knox, J Ryoo, BY Yau, TCC Abou-Alfa, GK	2019	34
	First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma Journal:Cancer Discovery	Kim, RD Sarker, D Meyer, T Yau, T Macarulla, T Park, JW Choo, SP Hollebecque, A Sung, MW Lim, HY Mazzaferro, V Trojan, J Zhu, AX Yoon, JH Sharma, S Lin, ZZ Chan, SL Faivre, S Feun, LG Yen, C-J Dufour, J-F Palmer, DH Llovet, JM Manoogian, M Tugnait, M Stransky, N Hagel, M Kohl, NE Lengauer, C Sherwin, CA Schmidt-Kittler, O Hoeflich, KP Shi, H Wolf, BB Kang, Y-K	2019	96
	Oxysterols Induce Cyclooxygenase-2 Expression in Cholangiocytes: Implications for Biliary Tract Carcinogenesis Journal:Hepatology	Yoon, JH Canbay, AE Werneburg, NW Lee, SP Gores, GJ	2004	160
	Phase 2a, randomized, double-blind, placebo-controlled study of an antisense inhibitor (ISIS 505358) in treatment-naïve chronic hepatitis B (CHB) patients: safety and antiviral efficacy Proceeding/Conference:Hepatology	Yuen, RMF Heo, J Jang, JW Yoon, JH Kweon, YO Park, SJ Bennett, CF Kwoh, TJ	2019	48
	Restoration of HBV-specific immune responses with therapeutic vaccine BRII-179 (VBI-2601) in chronic HBV patients in a phase 1b/ 2a study Proceeding/Conference:Journal of Hepatology	Ma, H Lim, TH Leerapun, A Weltman, M Jia, JD Lim, YS Tangkijvanich, P Sukeepaisarnjaroen, W Bert, NL Ji, Y Li, D Zhang, Y Hamatake, R Strasser, S Li, C Ding, H Yoon, JH Nigel, S Anderson, D Yan, L Bertoletti, A Zhu, Q Yuen, RMF	2021	16
	Results after 12 weeks treatment of multiple doses of GSK3389404 in chronic hepatitis B (CHB) subjects on stable nucleos(t)ide therapy in a phase 2a double-blind, placebo-controlled study Proceeding/Conference:Hepatology	Yuen, RMF Heo, J Kumada, H Suzuki, F Suzuki, Y Xie, Q Jia, JD Karino, Y Hou, JL Chayama, K Imamura, M lao-Tan, JY Lim, SG Tanaka, Y Xie, W Yoon, JH Duan, ZP Kurosaki, M Park, SJ Labio, E Kumar, R Kweon, YO Yim, HJ Cremer, J Elston, R Chen, SG Davies, M Baptiste-Brown, S Han, K Campbell, F Paff, M Theodore, D	2019	106
	RNA Interference Therapy With ARC‐520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection Journal:Hepatology	Yuen, MF Schiefke, I Yoon, JH Ahn, SH Heo, J Kim, JH Chan, HLY Yoon, KT Klinker, H Manns, M Petersen, J Schluep, T Hamilton, J Given, BD Ferrari, C Lai, CL Locarnini, SA Gish, RG	2020	20
	Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma Journal:Hepatology	Won, C Kim, BH Yi, EH Choi, KJ Kim, EK Jeong, JM Lee, JH Jang, JJ Yoon, JH Jeong, WI Park, IC Kim, TW Bae, SS Factor, VM Ma, SKY Thorgeirsson, SS Lee, YH Ye, SK	2015	69

Showing results 1 to 9 of 9